Up to 28% reduction in electricity costs with self-consumption solar power generation for the general-purpose pharmaceutical manufacturing industry.
Electricity costs for clean rooms and manufacturing lines reduced by up to 28%! Implementation with minimized risks is possible using a PPA model with zero initial costs and leveraging subsidies.
**[Problem Statement and Solution]** ■ Do you have any of these concerns? The electricity costs for clean rooms and air conditioning systems are enormous. Rising fuel adjustment costs and renewable energy surcharges are putting pressure on management. The entire pharmaceutical industry is being asked to comply with ESG and SDGs. ■ Comparison Before and After Implementation Before Implementation: Formulation, inspection, and packaging processes → High electricity costs After Implementation: Same processes + rooftop solar power for self-consumption during the day → Approximately 28% reduction in electricity costs and increased brand value through CO₂ reduction.
basic information
【Product Features】 Feature 1: Stabilization of Management through Fixed Electricity Costs Avoids the risk of fluctuating electricity prices and achieves long-term cost management. Feature 2: Optimal Power Composition for Pharmaceutical Factories Covers daytime operational loads such as GMP-compliant clean rooms and precision air conditioning. Feature 3: Zero Initial Costs with Subsidies & PPA Model Utilizes national and local government subsidies, allowing for a zero equipment cost start with a PPA.
Price information
Cost: Individual estimate based on factory roof area and contracted electricity capacity Subsidy utilization: Up to 2/3 subsidy (nationwide support)
Delivery Time
Applications/Examples of results
■ Implementation Case: Saitama Prefecture General Pharmaceutical Manufacturing Plant Implementation Capacity: 250kW (full utilization of the roof) Annual Electricity Cost Reduction: Approximately 7,200,000 yen Effect: Covers about 50% of the daytime clean room air conditioning power ■ Target Facility General Pharmaceutical (OTC drug) manufacturing plant Active ingredient manufacturing, packaging, and inspection lines Facilities with clean rooms and sterile rooms
